| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/15/2002 | CA2438127A1 Geometry retainable devices for body cavities |
| 08/15/2002 | CA2437375A1 Methods and compositions for reducing the taste of pharmaceutically active agents |
| 08/15/2002 | CA2437372A1 Oral itraconazole formulations and methods of making the same |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | CA2437212A1 Methods and devices for tissue repair |
| 08/15/2002 | CA2437087A1 Methods for the administration of amifostine and related compounds |
| 08/15/2002 | CA2436374A1 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | CA2434566A1 Parenteral formulation containing epothilone analogs |
| 08/15/2002 | CA2434079A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231268A2 Polyclonal antibody libraries |
| 08/14/2002 | EP1230935A2 Modified colloids and their use |
| 08/14/2002 | EP1230934A1 Polyion complex micelles of core/shell structure |
| 08/14/2002 | EP1230916A2 Aqueous medicament preparations for the production of propellant gas-free aerosols |
| 08/14/2002 | EP1230855A1 Sustained-release preparation of aqueous dispersion type and process for producing the same |
| 08/14/2002 | EP1230353A1 Bifunctional molecules and their use in the disruption of protein-protein interactions |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230338A1 Continuous-flow method for preparing microparticles |
| 08/14/2002 | EP1230270A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents |
| 08/14/2002 | EP1230267A2 Membrane translocating peptide drug delivery system |
| 08/14/2002 | EP1230250A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP1230003A2 A method of producing organic emulsifiers and organic surfactants, products produced by said method, and the use of such products |
| 08/14/2002 | EP1229942A1 Method and formula for tumor remission and suppression of cancer |
| 08/14/2002 | EP1229941A2 Nucleic acid-containing complex |
| 08/14/2002 | EP1229940A1 Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| 08/14/2002 | EP1229939A1 Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229932A2 Induction of mucosal immunity by vaccination via the skin route |
| 08/14/2002 | EP1229917A1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 08/14/2002 | EP1229913A1 Substituted 1-benzazepines and derivatives thereof |
| 08/14/2002 | EP1229909A2 Transdermal delivery of lasofoxifene |
| 08/14/2002 | EP1229905A2 Transdermal drug delivery devices comprising (r)-(z)-1- azabicyclo[2.2.1]heptan-3-one, o-[3(3-methoxyphenyl)-2-propynyl]oxime |
| 08/14/2002 | EP1229903A1 A method for chemoprevention of prostate cancer |
| 08/14/2002 | EP1229900A1 Sustained-release drug formulations for implantation |
| 08/14/2002 | EP1229897A2 Personal care articles comprising cationic polymer coacervate compositions |
| 08/14/2002 | EP1229793A1 Bifunctional molecules having modulated pharmacokinetic properties and therapies based thereon |
| 08/14/2002 | EP1077718B1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 08/14/2002 | EP1071455A4 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/14/2002 | EP1023039B1 Use of alkylmonoglucosides as molecular vectors |
| 08/14/2002 | EP0973519B1 Inclusion complexes in aqueous solution |
| 08/14/2002 | EP0969806B1 Keratotic plug remover |
| 08/14/2002 | EP0954329B1 Method of killing target cells in harvested cell populations with two immunotoxins |
| 08/14/2002 | EP0944675B1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 08/14/2002 | EP0907364B1 Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |
| 08/14/2002 | EP0817614B1 Stable protein-phospholipid compositions and method of preparation |
| 08/14/2002 | EP0806964B1 Chemical compounds |
| 08/14/2002 | EP0746342B1 Biodegradable controlled release melt-spun delivery system |
| 08/14/2002 | EP0701448B1 Amplification of the vitamin b 12 uptake system using polymers |
| 08/14/2002 | DE10105921A1 An Kolloide gebundene Arzneiwirkstoffe At colloids bound drug targets |
| 08/14/2002 | DE10104551A1 Verwendung eines Claudin-4-Liganden in der Therapie und Diagnose von Tumoren Use of a claudin-4 ligands in the therapy and diagnosis of tumors |
| 08/14/2002 | DE10103860A1 Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung Transdermal therapeutic system for the administration of carboxyl-containing, non-steroidal anti-inflammatory agents, and to processes for its preparation |
| 08/14/2002 | DE10103565A1 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle |
| 08/14/2002 | CN1364171A Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 08/14/2002 | CN1364083A Transdermal composition of antivomiting agent and preparation containing the same |
| 08/14/2002 | CN1364079A Transnasal anticonvulsive compositions and modulated process |
| 08/14/2002 | CN1364077A Multilayer pharmaceutical product for release in the colon |
| 08/14/2002 | CN1364076A Oral form of administration containing probiotic micro-organisms |
| 08/14/2002 | CN1364075A Ambroxol-containing lozenge |
| 08/14/2002 | CN1363555A Percutaneous absorption promoter and its synthesizing process and application |
| 08/14/2002 | CN1363394A Process for preparing nano particles of hydroxycamptothecine polylactate |
| 08/14/2002 | CN1088993C Long-acting subcutaneous contraceptive implanting agent containing pregnadienone |
| 08/13/2002 | US6433158 Dna comprising polynucleotide encoding polypeptide comprising specified amino acid sequence |
| 08/13/2002 | US6433152 Sophoroselipids, method for their production and use |
| 08/13/2002 | US6433143 Tie-2 ligands |
| 08/13/2002 | US6433135 Polyoxyethylene glycol luteinizing hormone releasing hormone bound for serine |
| 08/13/2002 | US6433061 Rheology modifying copolymer composition |
| 08/13/2002 | US6433040 Administering nonaqueous suspension in liquid fluorochemical with plurality of perforated microstructures filled with bioactive agent dispersed therin to nose or lungs; drug delivery |
| 08/13/2002 | US6433012 Administering methyl diiodo-benzoate derivatives as angiogenesis inhibitors; reducing tumor necrosis factor; treating inflammatory bowel and crohn*s disease |
| 08/13/2002 | US6433011 Method for inhibiting formation of aberrant crypt foci in the colon of a mammal |
| 08/13/2002 | US6433006 Method of treatment of seborrheic dermatitis |
| 08/13/2002 | US6433000 Aromatic sulfamate derivatives as sulfatase inhibitors; estrogen receptor blockers; breast cancer treatment |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432934 Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| 08/13/2002 | US6432928 Complexes and their compositions |
| 08/13/2002 | US6432920 Peptide library |
| 08/13/2002 | US6432700 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 08/13/2002 | US6432456 Contains as an effective component a water-soluble component of capsicum annuum l.var.grossumn which is a solanacede plant. |
| 08/13/2002 | US6432449 Anionic polysaccharides coupled with a metal and a complex leptin protein; biocompatible injections having no side effects |
| 08/13/2002 | US6432448 Time-release coatings containing microcrystalline cellulose, plant extracts, polymers and plasticizers used for drugs and veterinary solid dosage forms, candy, seeds, fertilizers, pesticide tablets, feeds and foods |
| 08/13/2002 | US6432447 Core of fluvastatin, hydroxypropyl methyl cellulose and optionally other excipients, dosage form is color-stable during storage |
| 08/13/2002 | US6432445 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 08/13/2002 | US6432442 Gelatin, hydroxypropyl cellulose, water, ibuprofen, acetaminophen, dextromethorphan or pseudoephedrine |
| 08/13/2002 | US6432441 Throat soothing compositions |
| 08/13/2002 | US6432440 Decongestants, contraceptives, lubricants or antiallergens, having low saponification numbers, administered as liquids, so that gelation may occur at physiologically ph and low calcium concentration |
| 08/13/2002 | US6432438 Biodegradable vehicle and filler |
| 08/13/2002 | US6432434 Administering lipoic or dihydrolipoic acid as neuroprotectants for nervous system disorders or traumas |
| 08/13/2002 | US6432432 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 08/13/2002 | US6432431 Steroid-containing cataplasms and process for producing the same |
| 08/13/2002 | US6432426 Contains molecular iodine in a concentration above at least 15 ppm and one of triiodide or complexed iodoine may be present; lower concentrations of iodine disinfect without staining skin |
| 08/13/2002 | US6432423 Polyethylenimine modified with thiobutyrolactone (4-mercaptobutyric acid); pendant mercaptans are oxidized to form disulfide bonds |
| 08/13/2002 | US6432422 Oil in water emulsion with maxacalcitol; improved skin absorption and heat stability |
| 08/13/2002 | US6432419 Using oils selected from the group consisting of dialkyl ethers, dialkyl cyclohexanes, guerbet alcohols, polyol polyhydroxystearates and/or hydroxycarboxylic acid esters |
| 08/13/2002 | US6432415 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 08/13/2002 | US6432409 Hybrid peptides modulate the immune response |
| 08/13/2002 | US6432402 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |